# FDA Inspection 1235622 - Temple University Hospital Bone Marrow Transplant Program - April 02, 2024

Source: https://www.keypedia.com/records/fda_inspections/temple-university-hospital-bone-marrow-transplant-program/8f0de29a-d7c7-407e-80d6-942d2387d6b9
Source feed: FDA_Inspections

> FDA Inspection 1235622 for Temple University Hospital Bone Marrow Transplant Program on April 02, 2024. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1235622
- Company Name: Temple University Hospital Bone Marrow Transplant Program
- Inspection Date: 2024-04-02
- Classification: No Action Indicated (NAI)
- Project Area: Human Cellular, Tissue, and Gene Therapies
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1235622 - 2024-04-02](https://www.keypedia.com/records/fda_inspections/temple-university-hospital-bone-marrow-transplant-program/0bc9582e-c9e2-4898-9901-35ea4665472a)

Company: https://www.keypedia.com/companies/temple-university-hospital-bone-marrow-transplant-program/ebc7c6bc-b98e-4adf-a6e1-fd1a4de66c5d

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d